NCT06524128

Brief Summary

Functional, independent mobility is essential for everyone (Fasciglione, 2017). It determines everyone's ability to engage in activities of daily living and contributes to maintaining health and well-being (Fasciglione, 2017). However, the number of people with mobility limitations is increasing. Indeed, due to the aging of the population and the growing number of people with chronic diseases, the prevalence of people experiencing mobility-related limitations is increasing rapidly (Berardi et al., 2021); in addition to this health problems (such as osteoarticular, muscular, neurological diseases) and accidents are the cause of 23.6% and 42% of mobility-related limitation situations respectively (Camirand \& Institut de la statistique du Québec, 2011). To overcome these limitations, some people require the use of a manual wheelchair to enable mobility. Globally, wheelchair mobility (manual or motorized) refers to "the ability to move independently with a wheelchair, and to overcome obstacles encountered in carrying out activities of daily living or social roles" (Routhier et al., 2003, p. 20). This definition emphasizes that the use of a wheelchair enables independent movement. In the past, the wheelchairs available were limited, expensive and rudimentary. Recent technological advances have given people access to a wide range of devices, adaptable to the majority of motor impairments and enabling movement in a wider variety of environments. Today's manual wheelchairs are increasingly sophisticated. However, they have no braking system other than the immobilizer that locks the wheels. Users have no choice but to use their hands as brake pads when gripping the handrail to slow down and stop. A preliminary survey conducted by EPPUR among 164 manual wheelchair users, between March and May 2020, has shown that 75% of manual wheelchair users express difficulty braking with their wheelchair or resort to assistance from a third party (EPPUR). Worryingly, 50% of survey respondents reported having lost control of their wheelchair on a slope or ramp. Finally, in their daily lives, 85% of respondents reported having already changed their route to avoid a slope. For wheelchair users, negotiating sloping streets means constant braking. The Dreeft® system was developed on the basis of these observations. No other system for braking manual wheelchairs is currently available. As described in the previous sections, the technology developed is based on the design of the hub which integrates the braking system, operating by back-pedaling. The manual wheelchair user benefits from improved responsiveness and manoeuvrability, with no friction on the hands. Adapted to manual wheelchairs, this innovative braking system is a potential revolution for users. In order to confirm the benefits and functional contribution of the Dreeft® device in real life, a clinical study will be carried out.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 22, 2024

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

July 23, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 29, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2025

Completed
Last Updated

October 6, 2025

Status Verified

October 1, 2025

Enrollment Period

10 months

First QC Date

July 23, 2024

Last Update Submit

October 1, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Canadian Measure of Occupational Performance (CMOP) - satisfaction score

    The Canadian Measure of Occupational Performance (CMOP) will be used to assess changes in perceived satisfaction with daily living tasks identified as priorities by the user, and involving mobility with the wheelchair.

    2 months

Secondary Outcomes (7)

  • Canadian Measure of Occupational Performance (CMOP) - performance score

    2 months

  • F-PIADS scale

    2 months

  • Wheelchair skill test - Questionnaire (WST-Q)

    2 months

  • QUEST measurement scale (Quebec User Evaluation of Satisfaction with assistive Technology)

    2 months

  • Vancouver scale

    2 months

  • +2 more secondary outcomes

Study Arms (2)

With Dreeft® wheels

EXPERIMENTAL

The participant's wheelchair will be equipped with DREEFT wheels, to be used for 1 month.

Device: Dreeft wheels (EPPUR company)

without Dreeft® wheels

NO INTERVENTION

The participant's wheelchair will be equipped with its usual braking system, monitored over a period of 1 month.

Interventions

The braking system (Dreeft wheels) is installed directly on the participant's wheelchair, by a trained occupational therapist. The Dreeft wheels are supplied for a period of 1 month.

With Dreeft® wheels

Eligibility Criteria

Age18 Years - 63 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male or female aged ≥ 18 years and \< to 64 years.
  • Participants having signed the written consent form to participate in the study after free and informed information.
  • Wheelchair user for more than one year.
  • Participants affiliated to a social security scheme (beneficiary or beneficiary's beneficiary) excluding AME.
  • Living at home.
  • Have a motor disability, whatever its origin, and use a manual wheelchair independently as their main mobility tool, with or without propulsion assistance.
  • Who propel their manual wheelchair with both upper limbs.
  • Using a personal manual wheelchair compatible with Dreeft® wheels.
  • Able to mount/dismount the wheels, or a third party to assist with wheel changes.
  • Referred by the person's referring physician or occupational therapist on clinical indication for the device.

You may not qualify if:

  • Participant deprived of liberty (by judicial or administrative decision).
  • Participant of legal age under legal protection or unable to express consent.
  • Participation in another ongoing clinical trial.
  • Pregnant or breastfeeding women or women of childbearing age without contraception.
  • Lack of proficiency in spoken and written French.
  • Unstable health condition.
  • Mentally or linguistically incapable of understanding the instructions for taking the research tests.
  • User unable to propel himself/herself independently in a manual wheelchair, hemiplegic user.
  • Body weight \> 120 kg

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Centre de rééducation et de réadaptation fonctionnelles de Kerpape

Ploemeur, 56270, France

Location

Centre de ressources et d'innovation mobilité handicap (CEREMH)

Vélizy-Villacoublay, 78140, France

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: This is a randomized, bicentric, single-blind, cross-over study.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 23, 2024

First Posted

July 29, 2024

Study Start

July 22, 2024

Primary Completion

May 15, 2025

Study Completion

May 15, 2025

Last Updated

October 6, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

Locations